A clinical diagnostic test providing comprehensive whole exome sequencing analysis for solid tumor patients. This service enables detection of genomic mutations across the entire exome for tumor profiling and treatment guidance.
Manufactured by
Shenzhen HaploX Biotechnology Co., Ltd.
China
HaploX Biotechnology specializes in tumor liquid biopsy and genetic big data technologies. The company operates CAP/CLIA/EMQN/NCCL certified medical laboratories equipped with advanced gene sequencing platforms. Services cover tumor management, hereditary disease screening, and infectious disease detection, serving hundreds of hospitals and research institutions across China with international operations in Hong Kong, Singapore, Japan, Europe, and North America.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
PreceDo Pharmaceuticals Co.Ltd.
China · 2 relevant products
Genes 2Me Private Ltd
India · 1 relevant product
Luoyang Geneture Medical Technology Co.,Ltd.
China · 2 relevant products
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →17 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 24 relevant matches
Luoyang Geneture Medical Technology Co.,Ltd. · China
Whole-exome sequencing-based genetic detection solution for comprehensive genomic analysis and disease risk assessment. Identifies pathogenic variants across the entire protein-coding genome to support clinical diagnosis, carrier screening, and personalized treatment planning.
Nonacus · United Kingdom
A research use only whole exome sequencing panel for comprehensive genomic analysis. Enables detection of variants across coding regions of the genome. Designed for translational research and exploratory genomic studies.
Blackhills Diagnostic Resources, S.L.U. BDR · Spain
A semi-automated kit for next-generation sequencing (NGS) of the exonic regions of the human genome, covering a 37.64 Mb region using genomic DNA extracted from whole blood and buccal swabs. The kit includes reagents for the preparation of DNA libraries enriched in exonic regions, intended for use on Illumina NGS sequencing platforms. It is designed for the identification of genetic variants in the exome to support the diagnosis of hereditary diseases, detect variants related to disease predisposition, and guide personalized medicine.
21 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products